Birchview Capital, LP Silk Road Medical Inc Transaction History

Birchview Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$11.38 - $19.03 $1.33 Million - $2.22 Million	116,800 Added 282.85%	158,094 $2.9 Million
Q3 2023 Nov 14, 2023	BUY	$14.99 - $32.65 $319,197 - $695,249	21,294 Added 106.47%	41,294 $618,000
Q2 2023 Aug 08, 2023	BUY	$29.76 - $46.14 $297,600 - $461,400	10,000 Added 100.0%	20,000 $649,000
Q1 2022 May 13, 2022	BUY	$29.24 - $44.06 $58,480 - $88,120	2,000 Added 25.0%	10,000 $413,000
Q4 2021 Feb 14, 2022	BUY	$39.32 - $61.61 $314,560 - $492,880	8,000 New	8,000 $341,000

3.48M

19.8K

Ticker SILK
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,565,600
Market Cap $1.03B
Description
Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.